Browsing Tag

Manufacturing

678 posts

Takeda Investing $126 M for New Mfg Facility, Expansion in California
By

By
Takeda is investing $126 million at its site in Thousand Oaks, California for a new 15,000-square-foot manufacturing facility and a renovation of 14,000-square feet of manufacturing space at its existing…

Global Pharma Briefs: News from Viatris, Janssen, and CureVac
By

By
A roundup of news from Canada (Bausch Health Companies), Germany (CureVac, Janssen, BioMed X) and the US (Viatris, Biocon). Canada Bausch Health Completes $740-M Sale of Amoun Pharmaceuticals Bausch Health…

Pharma COVID Roundup: News from Novavax, Moderna, Lilly, Regeneron
By

By
The latest on COVID-19 vaccines/drugs and manufacturing from Novavax, Moderna, Lilly, Regeneron, CureVac, Glenmark, and the World Health Organization. Manufacturing and supply of COVID-19 vaccines and drugs EU To Purchase…

BioNTech Acquires a Cell-Therapy Mfg Facility, R&D Platform from Gilead
By

By
BioNTech, a Mainz, Germany-based immunotherapy company, has completed its acquisition of a solid-tumor neoantigen T cell receptor (TCR) R&D platform and clinical manufacturing facility in Gaithersburg, Maryland from Kite, part…

BeiGene Plans To Build New Mfg, Clinical R&D Center in New Jersey
By

By
BeiGene, a Beijing-based bio/pharmaceutical company, has entered into a purchase agreement to acquire an approximately 42-acre site to build a new campus for R&D and manufacturing in Hopewell, New Jersey.…

Amgen To Invest $550 M in New Biomanufacturing Plant
By

By
Amgen has announced plans to invest $550 million to build a new multi-product biologic drug-substance manufacturing facility in Holly Springs, North Carolina. The new plant will support traditional stainless-steel-fed batch…

Pharma COVID Roundup: News from Pfizer, Moderna, and AstraZeneca
By

By
The latest on COVID-19 vaccines/drugs and manufacturing from Pfizer, Moderna, AstraZeneca, J&J, Emergent BioSolutions, Sanofi, GSK, Vir Biotechnology, BI, Sinovac, and others. Manufacturing and supply of COVID-19 vaccines and drugs…

Congress Seeks More Info from FDA on COVID’s Impact on Inspections
By

By
A bipartisan group of members of the US House of Representatives sent a letter to the US Food and Drug Administration (FDA) asking for additional information about the impact COVID-19…

Global Pharma Briefs: News from AstraZeneca, Merck KGaA, and Viatris
By

By
A roundup of news from Africa (BioNTech), China (Merck KGaA) and the US (AstraZeneca, Regeneron, Viatris, Takeda, BlueRock Therapeutics, and others). Africa BioNTech in Project for mRNA Malaria Vaccine; Evaluates…

Regeneron Plans $1.8-Bn Expansion
By

By
Regeneron Pharmaceuticals, a Tarrytown, New York-based bio/pharmaceutical company, plans to invest approximately $1.8 billion over six years to expand its research, preclinical manufacturing, and support facilities at its headquarters in…